Two WSLH-connected pilot projects were among five announced by the UW-Madison Institute for Clinical and Translational Research (ICTR) on August 3rd.
The ICTR Pilot Awards Program funds innovative projects that help move clinical discoveries into practice while advancing investigators’ careers. In addition to supporting experienced researchers, the program supports early career investigators as well as researchers who are new to clinical and translational research as they establish and advance their research careers.
The WSLH projects are:
Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
Contact PI: Heather Barkholtz, School of Pharmacy and WSLH Forensic Toxicology
Co-PI: Michael Chen, SMPH-Family Medicine & Community Health
Funded by ICTR
GLP-1 medications may alter alcohol absorption, but data are limited. This knowledge gap impacts clinical guidance, patient safety, and forensic interpretation of alcohol testing results. This study will characterize how individuals with obesity, receiving maintenance-dose of GLP-1, process alcohol over time and explore links to intoxication and impairment outcomes. The work will take place at UW’s Clinical Research Unit.
Improving Blastomyces Diagnosis and Treatment: A Pilot Study
Contact PI: Alana Sterkel, Wisconsin State Laboratory of Hygiene
Co-PI: Alexandra Linz, Marshfield Clinic Research Institute
Funded by ICTR
Blastomycosis remains a severe and frequently misdiagnosed fungal infection across Wisconsin, where delayed diagnosis contributes to avoidable death or lasting health problems. This pilot leverages an established partnership between UW–Madison (including the Wisconsin State Laboratory of Hygiene) and the Marshfield Clinic Research Institute to address the roadblocks that currently limit clinical adoption of improved Blastomyces diagnostics.


